Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:49763-96-4
Molecular Formula:C14H18O3
Alias
More Information
1-(1,3-Benzodioxol-5-Yl)-4,4-Dimethyl-1-Penten-3-Ol; 4,4-Dimethyl-1-(3,4-Methylenedioxyphenyl)-1-Penten-3-Ol; 4,4-Dimethyl-1-[3,4(Methylenedioxy)-Phenyl]-1-Penten-3-Ol,Diacomit; (E)-1-(1,3-Benzodioxol-5-Yl)-4,4-Dimethylpent-1-En-3-Ol; Diacomit; Bcx 2600
Brief Introduction
The action mechanism of stilamyl alcohol (slipantol) is unique. It can not only increase the release of GABA, but also inhibit the activity of some enzymes, so as to increase the blood concentration of other antiepileptic drugs. Stilamyl alcohol (slipantol) was approved in the EU in 2001 for adjuvant treatment of severe infantile epileptic myoclonic seizures.
CAS:497833-27-9
Molecular Formula:C24H27N3O4
Alias
More Information
Itf2357; (6-((Diethylamino)Methyl)Naphthalen-2-Yl)Methyl(4-(Hydroxycarbamoyl)Phenyl)Carbamate; Givinostat [Inn]; Ex-5958; Unii-5P60F84Fbh; Italfarmaco; Diethyl-[6-(4-Hydroxycarbamoyl-Phenylcarbamoyloxymethyl)-Naphthalen-2-Yl-Methyl]-Amine; Givinostat Free Base
Brief Introduction
Givinostat is an orally bioavailable hydroxymate inhibitor of histone deacetylase (HDAC) with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities. Givinostat inhibits class I and class II HDACs, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling and an altered pattern of gene expression. At low, nonapoptotic concentrations, this agent inhibits the production of pro-inflammatory cytokines such as tumor necrosis factor- (TNF-), interleukin-1 (IL-1), IL-6 and interferon-gamma. Givinostat has also been shown to activate the intrinsic apoptotic pathway, inducing apoptosis in hepatoma cells and leukemic cells. This agent may also exhibit anti-angiogenic activity, inhibiting the production of angiogenic factors such as IL-6 and vascular endothelial cell growth factor (VEGF) by bone marrow stromal cells.
CAS:499-67-2
Molecular Formula:C16H26N2O3
Alias
More Information
Proparacaine; 2-(Diethylamino)Ethyl 3-Amino-4-Propoxybenzoate; Ophthaine; Proximetacainum; Alcaine
Brief Introduction
Proparacaine is a benzoic acid derivative anesthetic agent, with local anesthetic activity. Upon administration, proparacaine stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels. This inhibits the sodium ion influx required for the initiation and conduction of impulses within the neuronal cell, increases the threshold for electrical stimulation and results in a loss of sensation.
CAS:50-35-1
Molecular Formula:C13H10N2O4
Alias
More Information
Thalomid; 2-(2,6-Dioxopiperidin-3-Yl)Isoindoline-1,3-Dione; Sedoval; (+/-)-Thalidomide; N-Phthalylglutamic Acid Imide; 3-Phthalimidoglutarimide; Alpha-Phthalimidoglutarimide; (+-)-Thalidomide; 2,6-Dioxo-3-Phthalimidopiperidine; Thalidomide Celgene; Alpha-N-Phthalylglutaramide; N-(2,6-Dioxo-3-Piperidyl)Phthalimide; Glutarimide, 2-Phthalimido-; N-Phthalyl-Glutaminsaeure-Imid; Alpha-(N-Phthalimido)Glutarimide; 1H-Isoindole-1,3(2H)-Dione, 2-(2,6-Dioxo-3-Piperidinyl)-; 1,3-Dioxo-2-(2,6-Dioxopiperidin-3-Yl)Isoindoline; .Alpha.-N-Phthalylglutaramide; Phthalimide, N-(2,6-Dioxo-3-Piperidyl)-; 2-(2,6-Dioxopiperidin-3-Yl)-1H-Isoindole-1,3(2H)-Dione; 2-(2,6-Dioxopiperidin-3-Yl)-2,3-Dihydro-1H-Isoindole-1,3-Dione; .Alpha.-Phthalimidoglutarimide; 2-(2,6-Dioxo-3-Piperidinyl)-1H-Isoindole-1,3(2H)-Dione
Brief Introduction
Thalidomide is a synthetic glutamate derivative, which is mainly used to treat epilepsy. However, due to its lack of effectiveness, thalidomide was subsequently used as a sleep adjuvant and widely used to stop vomiting during pregnancy. In the early 1960s, thalidomide was reported to cause a large number of infant malformations, which was banned by many countries and withdrawn from the pharmaceutical market. However, scientists did not completely deny thalidomide and continued to conduct in-depth research on it, especially in immunization, anti-inflammatory Gratifying and encouraging results have been obtained in the pharmacology of anti angiogenesis and the clinical treatment of some difficult diseases, so that people have a new understanding of thalidomide.
CAS:50-41-9
Molecular Formula:C32H36ClNO8
Alias
More Information
Clomiphene Citrate Salt; Diethylethanamine,Clomiphene Citrate Salt; {2-[4-(2-Chloro-1,2-Diphenylvinyl)Phenoxy]Ethyl}Diethylamine 2-Hydroxy-1,2,3-Propanetricarboxylate (Salt); 2-(4-(2-Chloro-1,2-Diphenylvinyl)Phenoxy)-N,N-Diethylethanamine 2-Hydroxypropane-1,2,3-Tricarboxylate; 2-[4-(2-Chloro-1,2-Diphenylethenyl)Phenoxy]-N,N-Diethyl-Ethanamine, 2-Hydroxy-1,2,3-Propanetricarboxylate; Clomifene Citrate
Brief Introduction
This product is an anti estrogen (fertility inducer), which is suitable for functional uterine bleeding, polycystic ovary, menstrual disorder, drug-induced amenorrhea and other gynecological diseases.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!